Concord medical announces the successful holding of the second annual academic meeting with the world well-known md anderson

Beijing , nov. 16, 2022 /prnewswire/ -- concord medical services holdings limited ("concord medical" or the "company") (nyse: ccm), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in china, today announced the successful holding of the second annual academic meeting (the "meeting") jointly by shanghai concord cancer center and the university of texas md anderson cancer center ("md anderson") on november 11 and november 12, 2022. with the theme of "immuno-oncology: confronting the whole cancer continuum," the meeting gathered a number of well-known oncologists and scholars from china and the united states to share their cutting-edge academic achievements in various ways, to promote academic communications and cooperation in oncology worldwide.
CCM Ratings Summary
CCM Quant Ranking